An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
California Pacific Medical Center · Pacific Eye Associates · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
970
total citations
- FWCI
- 80.15
- Percentile
- 100%
- References
- 9
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Ranibizumab
- Medicine
- Macular degeneration
- Visual acuity
- Ophthalmology
- Choroidal neovascularization
- Retinal
- Regimen
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.